Membranoproliferative glomerulonephritis (MPGN) is characterised by mesangial cell proliferation, thickening of the glomerular basement membrane, and immune complex deposition.
Classification of MPGN
| Classification | Description |
|---|---|
| Primary (immune complex-mediated) MPGN | Type I: subendothelial immune complex deposition; Type III: Subendothelial and subepithelial immune complex deposition |
| Secondary MPGN | Occurs in the setting of systemic disease, e.g., lupus nephritis, hepatitis C, cryoglobulinaemia, or monoclonal gammopathy |
| Complement-mediated MPGN (C3 glomerulopathy) | Includes dense deposit disease (DDD), and C3 glomerulonephritis which has minimal immunoglobulin involvement |
- Signs and symptoms
- Haematuria
- Proteinuria
- Hypertension
- Renal insufficiency
- Nephrotic syndrome or nephritic syndrome
- Investigations
- Urinalysis
- Urea and creatinine
- C3 and C4 complement levels
- Serology for autoimmune diseases and infection
- Serum or urine electrophoresis for monoclonal proteins
- Kidney biopsy is the gold standard test
- Treatment
- Immunosuppressive therapy
- Treat the underlying cause
- Supportive treatment for hypertension, proteinuria, and oedema
- Complement inhibition using monoclonal antibodies, e.g., eculizumab against C5
- Renal replacement therapy if indicated